keyword
https://read.qxmd.com/read/38283474/incidental-finding-of-post-transplant-erythrocytosis-after-renal-transplantation-in-a-patient-with-chronic-kidney-disease-a-case-report
#21
Nouman Anthony, Imran Khan, Abdullah Shah, Anum Tariq, Mudassar Khan
Renal transplant aims to provide a healthy substitute for the chronically damaged kidney while also correcting the anemia of chronic disease by producing erythropoietin for effective erythropoiesis. However, in a small number of renal transplant patients, the hematocrit continues to rise even after correction of the anemia, ultimately leading to abnormally increased hemoglobin and hematocrit. This condition is termed "post-transplant erythrocytosis" (PTE). We present a case of a 50-year-old male who was diabetic, positive for hepatitis B surface antigen, and negative for polymerase chain reaction...
December 2023: Curēus
https://read.qxmd.com/read/38269514/targeting-pi3k-p-akt-enos-nrf2-ho-1-and-nf-%C3%AE%C2%BAb-p53-signaling-pathways-by-angiotensin-1-7-protects-against-liver-injury-induced-by-ischemia-reperfusion-in-rats
#22
JOURNAL ARTICLE
Fatma Farrag Ali, Mostafa Mourad Mohammed, Youssef Hussein, Manar Fouli Gaber Ibrahim
The liver is an important organ, and hepatic ischemia-reperfusion (IR) injury is a frequent pathophysiological process that can cause significant morbidity and mortality. Thus, our study aimed to investigate the effect of targeting PI3K/p-Akt/eNOS (phosphoinositide 3-kinase/phospho-protein kinase B/endothelial nitric oxide synthase), Nrf2/HO-1 (nuclear factor-erythroid 2-related factor-2/heme oxygenase-1), and NF-κB/p53 (nuclear factor-κB/tumor protein 53) signaling pathways by using angiotensin (1-7) [ang-(1-7)] against hepatic injury induced by IR...
January 2024: Cell Biochemistry and Function
https://read.qxmd.com/read/38261266/pharmacogenetic-study-of-ces1-gene-and-enalapril-efficacy
#23
REVIEW
Misbah Hussain, Sehrish Basheer, Adila Khalil, Qurat Ul Ain Haider, Hafsa Saeed, Muhammad Faizan
Enalapril is an orally administered angiotensin-converting enzyme inhibitor which is widely prescribed to treat hypertension, chronic kidney disease, and heart failure. It is an ester prodrug that needs to be activated by carboxylesterase 1 (CES1). CES1 is a hepatic hydrolase that in vivo biotransforms enalapril to its active form enalaprilat in order to produce its desired pharmacological impact. Several single nucleotide polymorphisms in CES1 gene are reported to alter the catalytic activity of CES1 enzyme and influence enalapril metabolism...
January 23, 2024: Journal of Applied Genetics
https://read.qxmd.com/read/38240986/ace2-expressed-on-myeloid-cells-alleviates-sepsis-induced-acute-liver-injury-via-the-ang-1-7-mas-receptor-axis
#24
JOURNAL ARTICLE
Lei Liu, Ya Li, Jia-Xin Li, Xue Xiao, Tian-Tian Wan, Hui-Hua Li, Shu-Bin Guo
Sepsis-induced acute liver injury (ALI) is common in intensive care units. Angiotensin-converting enzyme 2 (ACE2) plays a vital role in hepatic fibrosis and steatosis; however, its role in sepsis-induced ALI remains unclear. This study found that hepatic ACE2 expression in cecal ligation and puncture (CLP)-treated mice significantly decreased 24 h after CLP. ACE2-transgenic (TG) mice exhibited a significant improvement in CLP-induced ALI, accompanied by the inhibition of hepatocyte apoptosis, oxidative stress, and inflammation, while ACE2-knockout mice demonstrated an opposite trend...
January 19, 2024: Inflammation
https://read.qxmd.com/read/38188145/chemical-and-spectroscopic-characterization-of-artemisinin-querctin-zinc-novel-mixed-ligand-complex-with-assessment-of-its-potent-high-antiviral-activity-against-sars-cov-2-and-antioxidant-capacity-against-toxicity-induced-by-acrylamide-in-male-rats
#25
JOURNAL ARTICLE
Samy M El-Megharbel, Safa H Qahl, Bander Albogami, Reham Z Hamza
A novel Artemisinin/Quercetin/Zinc (Art/Q/Zn) mixed ligand complex was synthesized, tested for its antiviral activity against coronavirus (SARS-CoV-2), and investigated for its effect against toxicity and oxidative stress induced by acrylamide (Acy), which develops upon cooking starchy foods at high temperatures. The synthesized complex was chemically characterized by performing elemental analysis, conductance measurements, FT-IR, UV, magnetic measurements, and XRD. The morphological surface of the complex Art/Q/Zn was investigated using scanning and transmission electron microscopy (SEM and TEM) and energy dispersive X-ray analysis (XRD)...
2024: PeerJ
https://read.qxmd.com/read/38169588/marked-hepatotoxicity-associated-with-losartan-treatment-a-case-report
#26
Iman Zahedi, Mohamed Sami, Olumide Ijishakin, Henry Onyemarim, Riyotta T Cutliff, Victor C Ezeamii
Losartan is a widely prescribed angiotensin II receptor blocker (ARB) used for the management of hypertension and various cardiovascular conditions. While it is generally considered a safe medication, rare cases of hepatotoxicity have been reported in the literature. We present a case of severe hepatic injury and sub-fulminant hepatitis attributed to losartan use in a 54-year-old male patient with underlying hypertension. He presented with a two-week history of abdominal pain, progressive jaundice, dark urine, and vomiting, followed by altered sensorium...
December 2023: Curēus
https://read.qxmd.com/read/38156281/pea-protein-hydrolysate-reduces-blood-glucose-in-high-fat-diet-and-streptozotocin-induced-diabetic-mice
#27
JOURNAL ARTICLE
Wang Liao, Xinyi Cao, Hui Xia, Shaokang Wang, Liang Chen, Guiju Sun
INTRODUCTION: Food proteins have been recognized as an ideal source to release bioactive peptides with the potential to intervene nutrition related chronic diseases, such as cardiovascular diseases, obesity and diabetes. Our previous studies showed that pea protein hydrolysate (PPH) could suppress hepatic glucose production in hepatic cells via inhibiting the gluconeogenic signaling. Thus, we hypothesized that PPH could play the hypoglycemic role in vivo. METHODS: In the present study, the mice model with type 2 diabetic mellitus (T2DM) was developed by high-fat diet and low dose of streptozotocin injections...
2023: Frontiers in Nutrition
https://read.qxmd.com/read/38113017/the-critical-intersect-of-regulations-health-technology-assessment-and-drug-safety-assessments
#28
JOURNAL ARTICLE
Wen-Wen Yang, Yi-Chen Juan, Grace Hui-Min Wu, Raoh-Fang Pwu
Health technology assessment (HTA) is a multidisciplinary process that determines the value of health technology at different points in its lifecycle. Safety issues have become more important since regulatory authorities are increasingly adopting flexible standards, processes, and evidentiary requirements for drug approval. In this article, we compared the different role of regulatory authorities and HTA agencies. Additionally, the experience of regulatory-HTA collaboration for assessment and/or decision-making on safety issues in the lifecycle of a health technology is illustrated, including olmesartan (angiotensin II receptor antagonist) and the direct-acting hepatitis C virus (HCV) antiviral agents...
December 19, 2023: Drug Safety: An International Journal of Medical Toxicology and Drug Experience
https://read.qxmd.com/read/38097064/blockade-of-angiotensin-ii-modulates-insulin-like-growth-factor-1-mediated-skeletal-muscle-homeostasis-in-experimental-steatohepatitis
#29
JOURNAL ARTICLE
Misako Tanaka, Kosuke Kaji, Norihisa Nishimura, Shohei Asada, Aritoshi Koizumi, Takuya Matsuda, Nobuyuki Yorioka, Yuki Tsuji, Yukihisa Fujinaga, Shinya Sato, Tadashi Namisaki, Takemi Akahane, Hitoshi Yoshiji
Sarcopenia is associated with mortality in patients with nonalcoholic steatohepatitis (NASH). Angiotensin II receptor blocker (ARB) has been suggested to prevent sarcopenia, but reports on its effect on NASH-derived skeletal muscle atrophy in conjunction with insulin-like growth factor 1 (IGF-1)-mediated muscle homeostasis are few. Our aim was to examine the combined effect of the ARB losartan and IGF-1 replacement on skeletal muscle atrophy in a methionine-choline deficient (MCD) diet-fed murine steatohepatitis model...
December 12, 2023: Biochimica et Biophysica Acta. Molecular Cell Research
https://read.qxmd.com/read/38074511/sars-cov-2-receptor-ace2-is-upregulated-by-fatty-acids-in-human-mash
#30
JOURNAL ARTICLE
Luis Cano, Lise Desquilles, Gevorg Ghukasyan, Gaëlle Angenard, Clémence Landreau, Anne Corlu, Bruno Clément, Bruno Turlin, Eric Le Ferrec, Caroline Aninat, Julie Massart, Orlando Musso
BACKGROUND & AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) results in steatosis, inflammation (steatohepatitis), and fibrosis. Patients with MASLD more likely develop liver injury in coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As viral RNA has been identified in liver tissues, we studied expression levels and cellular sources of the viral receptor angiotensin-converting enzyme 2 (ACE2) and coreceptors in MASLD and fibroinflammatory liver diseases...
January 2024: JHEP reports: innovation in hepatology
https://read.qxmd.com/read/38007081/a-review-of-the-epidemiological-and-laboratory-evidence-of-the-role-of-aluminum-exposure-in-pathogenesis-of-cardiovascular-diseases
#31
REVIEW
Alexey A Tinkov, Anatoly V Skalny, Jose L Domingo, Saeed Samarghandian, Anatoly A Kirichuk, Michael Aschner
The objective of the present study was to review the epidemiological and laboratory evidence on the role of aluminum (Al) exposure in the pathogenesis of cardiovascular diseases. Epidemiological data demonstrated an increased incidence of cardiovascular diseases (CVD), including hypertension and atherosclerosis in occupationally exposed subjects and hemodialysis patients. In addition, Al body burden was found to be elevated in patients with coronary heart disease, hypertension, and dyslipidemia. Laboratory studies demonstrated that Al exposure induced significant ultrastructural damage in the heart, resulting in electrocardiogram alterations in association with cardiomyocyte necrosis and apoptosis, inflammation, oxidative stress, inflammation, and mitochondrial dysfunction...
February 1, 2024: Environmental Research
https://read.qxmd.com/read/37947373/covid-19-associated-liver-injury-adding-fuel-to-the-flame
#32
REVIEW
Yingqian Wang, Min Shen, Yujia Li, Jiangjuan Shao, Feng Zhang, Mei Guo, Zili Zhang, Shizhong Zheng
COVID-19 is mainly characterized by respiratory disorders and progresses to multiple organ involvement in severe cases. With expansion of COVID-19 and SARS-CoV-2 research, correlative liver injury has been revealed. It is speculated that COVID-19 patients exhibited abnormal liver function, as previously observed in the SARS and MERS pandemics. Furthermore, patients with underlying diseases such as chronic liver disease are more susceptible to SARS-CoV-2 and indicate a poor prognosis accompanied by respiratory symptoms, systemic inflammation, or metabolic diseases...
November 10, 2023: Cell Biochemistry and Function
https://read.qxmd.com/read/37937559/role-of-enhancing-aerobic-capacity-in-countering-covid-19-induced-liver-injury-in-elderlies
#33
JOURNAL ARTICLE
Ayman A Mohamed, Ahmed A Abdalla, Yih-Kuen Jan
COVID-19 is still a world disaster; however, its vaccination is globally available. Liver and gastrointestinal disturbances occur in patients infected with COVID-19 at varying incidences. Aging decreases the functions of the liver. Thus, the elderly have a weaker response to the COVID-19 virus. The COVID-19 virus affects the liver directly through direct and indirect mechanisms. It directly affects the renin-angiotensin system or indirectly causes sepsis, uncontrolled immune reactions, drug-related hepatic injury, and cytokine storm...
November 1, 2023: Endocrine, Metabolic & Immune Disorders Drug Targets
https://read.qxmd.com/read/37923157/alamandine-treatment-prevents-lps-induced-acute-renal-and-systemic-dysfunction-with-multi-organ-injury-in-rats-via-inhibiting-inos-expression
#34
JOURNAL ARTICLE
H Saltuk Songür, Sinan Alperen Kaya, Yaşar Can Altınışık, Rukiye Abanoz, Esin Özçelebi, Füsun Özmen, Kemal Kösemehmetoğlu, Güray Soydan
Sepsis is defined as the dysregulated immune response leading to multi-organ dysfunction and injury. Sepsis-induced acute kidney injury is a significant contributor to morbidity and mortality. Alamandine (ALA) is a novel endogenous peptide of the renin-angiotensin-aldosterone system. It is known for its anti-inflammatory and anti-apoptotic effects, but its functional and vascular effects on sepsis remain unclear. We aimed to investigate the effects of ALA, as a pre- and post-treatment agent, on lipopolysaccharide (LPS)-induced systemic and renal dysfunction and injury in the LPS-induced endotoxemia model in rats via functional, hemodynamic, vascular, molecular, biochemical, and histopathological evaluation...
November 1, 2023: European Journal of Pharmacology
https://read.qxmd.com/read/37897397/emerging-insights-and-future-prospects-for-therapeutic-application-of-sirna-targeting-angiotensinogen-in-hypertension
#35
JOURNAL ARTICLE
Melisande L Addison, Priyanga Ranasinghe, David J Webb
INTRODUCTION: Hypertension is the main global risk factor for cardiovascular disease. Despite this, less than half of treated hypertensive patients are controlled. One reason for this is nonadherence, a major unmet need in hypertension pharmacotherapy. Small interfering RNA (small interfering ribonucleic acid) therapies inhibit protein translation, and, when linked to N-acetylgalactosamine, allow liver-specific targeting, and durability over several months. Targeted knockdown of hepatic angiotensinogen, the source of all angiotensins, offers a precision medicine approach...
October 28, 2023: Expert Review of Clinical Pharmacology
https://read.qxmd.com/read/37896826/a-5-lipoxygenase-inhibitor-zileuton-modulates-host-immune-responses-and-improves-lung-function-in-a-model-of-severe-acute-respiratory-syndrome-sars-induced-by-betacoronavirus
#36
JOURNAL ARTICLE
Rafaela das Dores Pereira, Rayane Aparecida Nonato Rabelo, Natália Fernanda de Melo Oliveira, Samuel Luiz Teixeira Porto, Ana Claudia Dos Santos Pereira Andrade, Celso M Queiroz-Junior, César Luís Nascimento Barbosa, Luiz Pedro de Souza-Costa, Felipe Rocha da Silva Santos, Fernando Bento Rodrigues Oliveira, Bárbara Luísa Vieira da Silva, Hanna L Umezu, Raquel Ferreira, Glauber S F da Silva, Jader Santos Cruz, Mauro Martins Teixeira, Vivian Vasconcelos Costa, Fabiana Simão Machado
Exacerbated inflammatory responses are a hallmark of severe coronavirus disease 2019 (COVID-19). Zileuton (Zi) is a selective inhibitor of 5-lipoxygenase, an enzyme involved in the production of several inflammatory/pro-resolving lipid mediators. Herein, we investigated the effect of Zi treatment in a severe acute respiratory syndrome (SARS) model. Mouse hepatitis virus (MHV)3-infected mice treated with Zi significantly improved the clinical score, weight loss, cardiopulmonary function, and survival rates compared with infected untreated animals...
October 4, 2023: Viruses
https://read.qxmd.com/read/37895950/anti-viral-activity-of-bioactive-molecules-of-silymarin-against-covid-19-via-in-silico-studies
#37
JOURNAL ARTICLE
Chunye Zhang, Yuxiang Sui, Shuai Liu, Ming Yang
The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection drove the global coronavirus disease 2019 (COVID-19) pandemic, causing a huge loss of human life and a negative impact on economic development. It is an urgent necessity to explore potential drugs against viruses, such as SARS-CoV-2. Silymarin, a mixture of herb-derived polyphenolic flavonoids extracted from the milk thistle, possesses potent antioxidative, anti-apoptotic, and anti-inflammatory properties. Accumulating research studies have demonstrated the killing activity of silymarin against viruses, such as dengue virus, chikungunya virus, and hepatitis C virus...
October 17, 2023: Pharmaceuticals
https://read.qxmd.com/read/37883863/lcz696-attenuates-sepsis-induced-liver-dysfunction-in-rats-the-role-of-oxidative-stress-apoptosis-and-jnk1-2-p38-signaling-pathways
#38
JOURNAL ARTICLE
Reham H Mohyeldin, Rania Alaaeldin, Ehab E Sharata, Mina Ezzat Attya, Eyad Y Elhamadany, Moustafa Fathy
AIM: Sepsis is a serious inflammatory response to infection with an annual incidence rate of >48 million cases and 11 million fatalities worldwide. Furthermore, sepsis remains the world's fifth-greatest cause of death. For the first time, the current study aims to evaluate the possible hepatoprotective benefits of LCZ696, a combination of an angiotensin receptor blocker (valsartan) and a neprilysin inhibitor prodrug (sacubitril), on cecal ligation and puncture (CLP)-induced sepsis in rats...
October 24, 2023: Life Sciences
https://read.qxmd.com/read/37866666/angiotensin-ii-type-2-receptor-attenuates-liver-fibrosis-progression-by-suppressing-ire1%C3%AE-xbp1-pathway
#39
JOURNAL ARTICLE
Yue An, Changyong Xu, Wenmin Liu, Ji Jiang, Pengfei Ye, Mei Yang, Weihua Zhu, Jingjing Yu, Manman Yu, Wuyi Sun, Jian Hong, Huan Qiu, Wei Wei, Shihao Zhang
The renin-angiotensin system (RAS) has been recognized as a crucial contributor to the development of liver fibrosis, and AT2R, an essential component of RAS, is involved in the progression of liver fibrosis. However, the underlying mechanisms by which AT2R modulates liver fibrosis remain elusive. Here, we report that AT2R was induced to be highly expressed during the progression of liver fibrosis, and the elevated AT2R attenuates liver fibrosis by suppressing IRE1α-XBP1 pathway. In this study, we found that AT2R is not expressed in the no cirrhotic adult liver, but is induced expression during liver fibrosis in both cirrhotic patients and fibrotic mice models...
October 20, 2023: Cellular Signalling
https://read.qxmd.com/read/37855126/targeting-angiotensinogen-with-n-acetylgalactosamine-conjugated-small-interfering-rna-to-reduce-blood-pressure
#40
REVIEW
Dien Ye, Edwyn O Cruz-López, Ho-Chou Tu, Ivan Zlatev, A H Jan Danser
Blood pressure management involves antihypertensive therapies blocking the renin-angiotensin system (RAS). Yet, it might be inadequate due to poor patient adherence or the so-called RAS escape phenomenon, elicited by the compensatory renin elevation upon RAS blockade. Recently, evidence points toward targeting hepatic AGT (angiotensinogen) as a novel approach to block the RAS pathway that could circumvent the RAS escape phenomenon. Removing AGT, from which all angiotensins originate, should prevent further angiotensin generation, even when renin rises...
December 2023: Arteriosclerosis, Thrombosis, and Vascular Biology
keyword
keyword
46017
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.